Distribution parallels distribution of all biotechnology companies with main states being Victoria then New South Wales. Western Australia has disproportionately more than Queensland which suggests that they may be more fragile.
Major Sector is Human Health followed by Equipment and Services then daylight
Most companies established at turn of century or in recent years
37% of companies valued less than $20 million and 52% less than $40 million
46% of companies are less than $20 million and 57% less than $40 million (Invex Therapeutics is valued at less than its cash holding)
55% of companies turn over less than $2 million and 64% turn over less than $5 million
